| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 117,752 | 126,618 | 119,330 | 130,363 | | Cost of Revenue | 98,419 | 101,023 | 96,247 | 120,248 | | | Gross Profit | 19,333 | 25,595 | 23,083 | 10,115 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,652 | 6,443 | 7,506 | 8,319 | | Non Recurring | (797) | 774 | 119 | 28,404 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,478 | 18,378 | 15,458 | (26,608) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,545 | 8,703 | 41 | 736 | | Earnings Before Interest And Taxes | 20,023 | 27,081 | 15,499 | (25,872) | | Interest Expense | 5,299 | 5,879 | 5,910 | 6,134 | | Income Before Tax | 14,724 | 21,202 | 9,589 | (32,006) | | Income Tax Expense | 3,886 | 8,000 | 3,873 | 3,641 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,838 | 13,202 | 5,716 | (35,647) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,838 | 13,202 | 5,716 | (35,647) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,838 | $13,202 | $5,716 | ($35,647) |
|
1.48% Nasdaq 
Income Statement
